| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |